1. Home
  2. ICFI vs ANIP Comparison

ICFI vs ANIP Comparison

Compare ICFI & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICF International Inc.

ICFI

ICF International Inc.

HOLD

Current Price

$79.67

Market Cap

1.8B

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$76.78

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICFI
ANIP
Founded
1969
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2006
1999

Fundamental Metrics

Financial Performance
Metric
ICFI
ANIP
Price
$79.67
$76.78
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$99.25
$107.33
AVG Volume (30 Days)
121.6K
309.9K
Earning Date
04-03-2026
03-26-2026
Dividend Yield
0.75%
N/A
EPS Growth
33.79
N/A
EPS
4.01
2.15
Revenue
$1,229,162,000.00
$206,547,000.00
Revenue This Year
N/A
$44.10
Revenue Next Year
$2.52
$13.18
P/E Ratio
$18.74
$35.49
Revenue Growth
3.72
2.47
52 Week Low
$72.03
$56.71
52 Week High
$101.71
$99.50

Technical Indicators

Market Signals
Indicator
ICFI
ANIP
Relative Strength Index (RSI) 42.46 43.96
Support Level $74.24 $75.20
Resistance Level $88.80 $84.47
Average True Range (ATR) 3.53 2.52
MACD -0.43 -0.15
Stochastic Oscillator 40.15 39.91

Price Performance

Historical Comparison
ICFI
ANIP

About ICFI ICF International Inc.

ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: